Using mobile technology to increase adherence to sublingual immunotherapy: Real-world study with a new app/web platform AllergyVax®

Using mobile technology to increase adherence to sublingual immunotherapy: Real-world study with a new app/web platform AllergyVax®

Allergen immunotherapy (AIT) is a key therapeutic approach for allergic rhinitis and asthma, demonstrating the ability to modify disease progression by targeting type 2 inflammation. This study evaluates the efficacy of a mobile application (app/web platform) AllergyVax®, designed to implement a pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Matheus Fonseca Aarestrup, MD, Akinori Cardozo Nagato, PhD, Paula Fonseca Aarestrup, MD, Edir Paula Cheloni, MD, Beatriz Julião V. Aarestrup, PhD, José Otávio Amaral Correa, PhD, Fernando Monteiro Aarestrup, MD PhD
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:World Allergy Organization Journal
Subjects:
SLIT
Allergen immunotherapy
Adherence
App
Web
Technology
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455125000419
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1939455125000419

Similar Items